Company Marksans Pharma Limited

Equities

MARKSANS

INE750C01026

Pharmaceuticals

Market Closed - NSE India S.E. 07:43:48 2024-04-26 am EDT 5-day change 1st Jan Change
172.2 INR +2.99% Intraday chart for Marksans Pharma Limited -1.23% +6.86%

Business Summary

Marksans Pharma Limited is an India-based pharmaceutical company. The Company is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulations. The Company produces goods across various therapeutic areas, such as pain management, cough and cold, cardiovascular and central nervous system, anti-diabetic, gastrointestinal, hormonal treatment, and anti-allergic, among others. The Company operates four manufacturing facilities across India, the United Kingdom and the United States. The Company manufactures oral solid tablets, soft gelatin capsules and hard capsules in Goa. It also manufactures non-sterile liquids, ointments and powder products and caters to the United Kingdom, West Africa and the Middle East, which is located in the United Kingdom. The Company has spread its facility to over 7000 square meters and manufactures tablets and capsules in the United States.

Number of employees: 852

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceuticals
100.0 %
14,908 100.0 % 18,521 100.0 % +24.23%

Sales per region

INR in Million2022Weight2023Weight Delta
United States & North America
41.8 %
6,351 42.6 % 7,746 41.8 % +21.97%
Europe and United Kingdom
41.4 %
6,091 40.9 % 7,676 41.4 % +26.02%
Australia and New Zealand
11.3 %
1,798 12.1 % 2,095 11.3 % +16.51%
Rest of World
5.2 %
669 4.5 % 971 5.2 % +45.10%
India
0.2 %
-- 34 0.2 % -

Managers

Managers TitleAgeSince
Chief Executive Officer 52 92-04-15
Director of Finance/CFO 54 02-09-05
Compliance Officer - -
Director/Board Member 70 16-07-04

Members of the board

Members of the board TitleAgeSince
Director/Board Member 49 21-08-10
Chief Executive Officer 52 92-04-15
Director/Board Member 52 14-09-24
Director/Board Member 70 16-07-04
Director/Board Member 51 18-03-13
Director/Board Member 71 11-10-04
Director/Board Member 54 16-04-30
Director/Board Member 58 23-05-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 453,163,746 253,747,549 ( 55.99 %) 0 55.99 %

Shareholders

NameEquities%Valuation
198,491,553 43.80 % 361 M ₹
Orbimed Asia IV Mauritius FVCI Ltd.
10.88 %
49,324,324 10.88 % 90 M ₹
quant Money Managers Ltd.
2.790 %
12,641,259 2.790 % 23 M ₹
UTI Asset Management Co. Ltd. (Investment Management)
1.277 %
5,788,805 1.277 % 11 M ₹
Pension Reserves Investment Management Board
0.2126 %
963,372 0.2126 % 2 M ₹
Government of India
0.1436 %
650,852 0.1436 % 1 M ₹
Gfund Management Co., Ltd.
0.1406 %
637,046 0.1406 % 1 M ₹
Motilal Oswal Asset Management Co. Ltd.
0.0681 %
308,421 0.0681 % 560 429 ₹
Dimensional Fund Advisors Ltd.
0.0649 %
294,246 0.0649 % 534 671 ₹
220,180 0.0486 % 400 087 ₹

Company contact information

Marksans Pharma Ltd.

Oshiwara, Andheri West Grandeur, Veera Desai Extension Road

400053, Mumbai

+91 22 4001 2000

http://www.marksanspharma.com
address Marksans Pharma Limited(MARKSANS)

Group companies

NameCategory and Sector
Pharmaceuticals: Major

Sales per region

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
172.2
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. MARKSANS Stock
  4. Company Marksans Pharma Limited